KBU2046
Product Specifications
CAS Number
1143863-69-7
Target
Others, HSP
Related Pathways
Cytoskeletal Signaling, Metabolism, Others
Purity
0.9989
Bioactivity
KBU2046 is an orally administered compound that inhibits cell motility and invasion, effectively suppressing cancer metastasis and extending lifespan. This compound uniquely targets and binds to chaperone heterocomplexes, selectively modifying the interaction of client proteins involved in motility regulation, while avoiding the characteristics typical of classical HSP90 inhibitors.
Smiles
Fc1ccc(cc1)C1COc2ccccc2C1=O
Molecular Formula
C15H11FO2
Molecular Weight
242.24
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15113428 1 Vial
Lentiviral human COX5A shRNA (UAS) - Lentiviral human COX5A shRNA (UAS, iRFP) plasmid
Sign In for Pricing
View Details 
IRBAHUITPR3AP46120UL 120 µL
Rabbit Anti Human ITPR3 Polyclonal Affinity Purified (PBS with 0.05% sodium azide and 50% glycerol, pH7.4) (IHC,ELISA) 120UL
Sign In for Pricing
View Details LV791651 1.0 µg DNA
FSCN3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)
Sign In for Pricing
View Details 